Colorectal cancer differs from patient to patient. That is why scientists are looking for characteristic tumor markers that allow them to make predictions about the likely response to certain therapies and the individual ...
May 16, 2024
0
1
The U.S. Food and Drug Administration has approved Genentech's Alecensa (alectinib) as adjuvant treatment following tumor resection in patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC).
Apr 23, 2024
0
0
Ultrasound imaging offers a valuable and noninvasive way to find and monitor cancerous tumors. However, much of the most crucial information about a cancer, such as specific cell types and mutations, cannot be learned from ...
May 13, 2024
0
0
Lung cancer remains a leading global health concern, responsible for the highest number of cancer-related deaths worldwide. Central to its development is the tumor microenvironment, which involves a complex interplay with ...
May 15, 2024
0
1
Researchers at Karolinska Institutet in Sweden have succeeded in delivering targeted cancer treatment via small membrane bubbles that our cells use to communicate. A study, "Antibody-displaying extracellular vesicles for ...
May 20, 2024
0
36
Cancer is a leading cause of death globally. One of the primary reasons why cancer is such a deadly disease is the ability of cancer cells to become drug-resistant.
May 15, 2024
0
0
Most patients with brain tumors receive one of two types of radiation: external beam radiation, in which the tumor is treated over the course of several weeks, or radiosurgery, in which patients receive a high dose of radiation ...
May 6, 2024
0
0
In a development in cancer research, scientists are exploring new therapeutic strategies that move beyond traditional cytotoxic treatments, which have historically targeted uncontrolled cell proliferation.
Apr 30, 2024
0
0
When cells become tumor cells, their metabolism changes fundamentally. Researchers at the University of Basel and the University Hospital Basel have now demonstrated that this change leaves traces that could provide targets ...
May 21, 2024
0
25
As the numbers of pediatric brain cancer survivors continue improving, the numbers of individuals developing life-long neurocognitive impairments are consequently expected to rise.
May 6, 2024
0
0
